Addgene: SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Skip to main content
Addgene

SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance.

Kim D, Fiske BP, Birsoy K, Freinkman E, Kami K, Possemato RL, Chudnovsky Y, Pacold ME, Chen WW, Cantor JR, Shelton LM, Gui DY, Kwon M, Ramkissoon SH, Ligon KL, Kang SW, Snuderl M, Vander Heiden MG, Sabatini DM
Nature. 2015 Apr 16;520(7547):363-7. doi: 10.1038/nature14363. Epub 2015 Apr 8. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

Antibodies from Article